LX1033
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for LX1033, covering 2012-07-20 to 2015-03-23. Get the full timeline:
Most recent: Clinical Trial Update: A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome [Phase 2]